CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- SB-2/A Other SB-2/A
- UPLOAD Other SEC-generated Letter
- SB-2/A Other SB-2/A
- UPLOAD Other SEC-generated Letter
- SB-2/A Other SB-2/A
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-A12G Other 8-A12G
- SB-2/A Other SB-2/A
- UPLOAD Other SEC-generated Letter
- SB-2 Other SB-2
- 10QSB Other 10QSB
- 8-K Event Executive or director change · Other events
Page 43 of 44 · 872 filings